3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatitis C
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
Radiotherapy, Conformal
2
Ifosfamide
2
Doxorubicin
2
romidepsin
1
indolepropanol phosphate
1
etoposide phosphate
1
Watchful Waiting
1
Vincristine
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Polymerase Chain Reaction
1
Observation
1
Neoadjuvant Therapy
1
Irinotecan
1
HhAntag691
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Filgrastim
1
Etoposide
1
Dactinomycin
1
Cyclophosphamide
1
Blotting, Western
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Malignant mesenchymal tumor
×
Chromatography, High Pressure Liquid
×
Clear all
No trials found.